Cargando…
The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1
Systemic inflammation gives rise to metabolic and behavioural changes, largely mediated by pro-inflammatory cytokines and prostaglandin production (PGE(2)) at the blood–brain barrier. Despite numerous studies, the exact biological pathways that give rise to these changes remains elusive. This study...
Autores principales: | Teeling, J.L., Cunningham, C., Newman, T.A., Perry, V.H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098384/ https://www.ncbi.nlm.nih.gov/pubmed/19931610 http://dx.doi.org/10.1016/j.bbi.2009.11.006 |
Ejemplares similares
-
Toward Multitasking Pharmacological COX-Targeting Agents: Non-Steroidal Anti-Inflammatory Prodrugs with Antiproliferative Effects
por: Grande, Fedora, et al.
Publicado: (2021) -
Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?
por: Khan, Shanzana, et al.
Publicado: (2019) -
Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors
por: Ahmadi, Mohsen, et al.
Publicado: (2022) -
Differential COX-2 induction by viral and bacterial PAMPs: Consequences for cytokine and interferon responses and implications for anti-viral COX-2 directed therapies()
por: Kirkby, Nicholas S., et al.
Publicado: (2013) -
Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years
por: Ju, Zhiran, et al.
Publicado: (2022)